Skip to main content

Table 1 Demographic data and medical history

From: Povidone-iodine pleurodesis versus talc pleurodesis in preventing recurrence of malignant pleural effusion

 

Group A

Group B

pvalue

 

N: 21 patients

N: 18 patients

 

Sex

  

0.442

 Male*

7 (33.3%)

4 (22.2%)

 

 Female*

14 (66.7%)

14 (77.8%)

 

Age (years)^

71.0 ± 5.0

70.9 ± 5.1

0.949

Weight (kg.)^

77.9 ± 5.3

77.1 ± 5.7

0.652

Height (cm.)^

174.0 ± 5.5

174.7 ± 5.5

0.687

BMI^

25.3±1.9

24.8±1.8

0.428

Primary tumor

  

0.480

 Lung*

5 (23.9%)

6 (33.3%)

 

 Breast*

9 (42.9%)

9 (50%)

 

 Unknown*

7 (33.3%)

3 (16.6%)

 

Symptoms

   

 Dyspnea*

20 (95.3%)

18 (100%)

0.348

 Cough*

8 (38.1% )

7 (38.8%)

0.959

 Chest pain*

10 (52.3%)

9 (50%)

0.882

Previous thoracocentesis

   

 Number/month^

4.7 ± 1.8

4.7 ± 1.5

0.926

 Total amount (liters)^

2.7 ± 0.5

2.8 ± 0.4

0.246

 Re-collection after (days)^

6.1 ± 2.3

6.7 ± 1.5

0.421

 Relief of symptoms*

21 (100%)

18 (100%)

1.00

Complete lung inflation*

21 (100%)

16 (87.8%)

0.117

  1. *Number (%).
  2. ^mean ± SD.